ES8801838A1 - Procedimiento para la obtencion de peptidos - Google Patents

Procedimiento para la obtencion de peptidos

Info

Publication number
ES8801838A1
ES8801838A1 ES548014A ES548014A ES8801838A1 ES 8801838 A1 ES8801838 A1 ES 8801838A1 ES 548014 A ES548014 A ES 548014A ES 548014 A ES548014 A ES 548014A ES 8801838 A1 ES8801838 A1 ES 8801838A1
Authority
ES
Spain
Prior art keywords
atoms
cycloalkyl
alkyl
peptides
cph2p
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES548014A
Other languages
English (en)
Other versions
ES548014A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES548014A0 publication Critical patent/ES548014A0/es
Publication of ES8801838A1 publication Critical patent/ES8801838A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE PEPTIDOS, DE FORMULA GENERAL (I), Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN LIBERAR EN UN COMPUESTO DE FORMULA GENERAL (I), EN LA QUE X SIGNIFICA HIDROGENO, R3-O-CH2-CO O R3-CMH2M-CO-; Z SIGNIFICA DE 1 A 4 RESTOS DE AMINOACIDO TIPO PEPTIDO, UNIDOS ENTRE SI; R SIGNIFICA AR-ALQUILO O CICLOALQUIL-ALQUILO CON 4 A 11 ATOMOS DE CARBONO; Y SIGNIFICA HIDROGENO O -CONA2; Y N SIGNIFICA 0, 1, 2, 3, 4 O 5, UNO DE SUS DERIVADOS FUNCIONALES, MEDIANTE TRATAMIENTO CON UN AGENTE HIDROGENOLIZANTE A TEMPERATURAS COMPRENDIDAS ENTRE 0 Y 100 GRADOS Y A PRESIONES COMPRENDIDAS ENTRE 1 Y 200 BARES. DE APLICACION EN MEDICINA POR SU ACTIVIDAD INHIBIDORA DE LA PLASMA-RENINA HUMANA.
ES548014A 1984-10-20 1985-10-18 Procedimiento para la obtencion de peptidos Expired ES8801838A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843438545 DE3438545A1 (de) 1984-10-20 1984-10-20 Peptide

Publications (2)

Publication Number Publication Date
ES548014A0 ES548014A0 (es) 1988-02-16
ES8801838A1 true ES8801838A1 (es) 1988-02-16

Family

ID=6248412

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548014A Expired ES8801838A1 (es) 1984-10-20 1985-10-18 Procedimiento para la obtencion de peptidos

Country Status (10)

Country Link
US (1) US4709010A (es)
EP (1) EP0179352B1 (es)
JP (1) JPS61100594A (es)
AT (1) ATE84042T1 (es)
AU (1) AU586647B2 (es)
CA (1) CA1276399C (es)
DE (2) DE3438545A1 (es)
ES (1) ES8801838A1 (es)
HU (1) HU196609B (es)
ZA (1) ZA858040B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3536687A1 (de) * 1985-10-15 1987-04-16 Hoechst Ag Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit
ZA87563B (en) * 1986-02-03 1987-09-30 Squibb & Sons Inc N-heterocyclic alcohol renin inhibitors
US4743585A (en) * 1986-11-21 1988-05-10 Warner-Lambert Company Renin inhibitors
DE3717631A1 (de) * 1987-05-26 1988-12-15 Merck Patent Gmbh Aminosaeurederivate
JPH02504143A (ja) * 1987-06-29 1990-11-29 ジ・アップジョン・カンパニー リンゴ酸誘導体含有レニン抑制ペプチド
EP0444156A4 (en) * 1988-11-21 1992-12-09 Abbott Laboratories Method for treating vascular diseases
US5268164A (en) * 1990-04-23 1993-12-07 Alkermes, Inc. Increasing blood-brain barrier permeability with permeabilizer peptides
US6864240B1 (en) 1999-06-15 2005-03-08 Elan Pharmaceuticals, Inc. Dipeptide inhibitors of β-secretase
US9120040B2 (en) * 2011-05-26 2015-09-01 The University Of Akron Anti-fouling materials based on poly(β-peptoid)s

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609643A (en) * 1980-08-06 1986-09-02 Aktiebolaget Hassle Renin inhibitors, treatments and dipeptide synthesis
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
CA1258748A (en) * 1981-10-08 1989-08-22 Daniel F. Veber Renin inhibitory peptides
CA1245217A (en) * 1981-12-10 1988-11-22 Joshua S. Boger Renin inhibitory peptides having phe su13 xx deletion
US4650661A (en) * 1982-09-15 1987-03-17 Aktiebolaget Hassle Enzyme inhibitors
US4668770A (en) * 1982-12-27 1987-05-26 Merck & Co., Inc. Renin inhibitory tripeptides
FI843837A7 (fi) * 1983-02-07 1984-09-28 Ab Haessle Entsyymi-inhibiittorit.
GB8305985D0 (en) * 1983-03-04 1983-04-07 Szelke M Enzyme inhibition
CA1254699A (en) * 1984-03-12 1989-05-23 Jasjit S. Bindra Renin inhibitors containing statine or derivatives thereof
US4663310A (en) * 1984-04-04 1987-05-05 Merck & Co., Inc. Renin inhibitors containing 2-substituted statine
DE3418491A1 (de) * 1984-05-18 1985-11-21 Merck Patent Gmbh, 6100 Darmstadt Diaminosaeurederivate
EP0163237A3 (en) * 1984-05-29 1988-04-27 Merck & Co. Inc. Di- and tri-peptidal renin inhibitors
US4645759A (en) * 1984-06-22 1987-02-24 Abbott Laboratories Renin inhibiting compounds
US4652551A (en) * 1984-06-22 1987-03-24 Abbott Laboratories Renin inhibiting compounds
IL78314A0 (en) * 1985-04-03 1986-07-31 Biotechnology Res Ass Expression vectors and methods for the production of recombinant human renin
US4657931A (en) * 1985-05-15 1987-04-14 G. D. Searle & Co. N-(acyldipeptidyl)-aminoglycols
US4665055A (en) * 1985-06-17 1987-05-12 Merck & Co., Inc. Peptide renin inhibitors

Also Published As

Publication number Publication date
AU586647B2 (en) 1989-07-20
EP0179352B1 (de) 1992-12-30
DE3438545A1 (de) 1986-04-24
ES548014A0 (es) 1988-02-16
HU196609B (en) 1988-12-28
JPS61100594A (ja) 1986-05-19
CA1276399C (en) 1990-11-13
EP0179352A3 (en) 1989-04-19
HUT42504A (en) 1987-07-28
ATE84042T1 (de) 1993-01-15
AU4891785A (en) 1986-04-24
US4709010A (en) 1987-11-24
DE3586936D1 (en) 1993-02-11
ZA858040B (en) 1986-06-25
EP0179352A2 (de) 1986-04-30

Similar Documents

Publication Publication Date Title
UA35636C2 (uk) Поліпептид, який має активність легеневої поверхнево-активної речовини, та фармацевтична композиція для лікування респіраторного дистрес-синдрому у ссавців
AU3458889A (en) Anti-aggregatory peptides
CA2027936A1 (en) Cyclic anti-aggregatory peptides
ATE73459T1 (de) Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten.
AU587186B2 (en) Diamino acid derivatives
CA2050300A1 (en) Tnf-inhibiting proteins and the preparation thereof
ES8801838A1 (es) Procedimiento para la obtencion de peptidos
CA2002924A1 (en) Anti-Thrombins
MY104909A (en) Peptide compounds.
EP0182627A3 (en) Basic v1-vasopressin antagonists
AU682638B2 (en) Peptide, bronchodilator and blood flow ameliorant
NZ334714A (en) Liver proteins as agents against autoimmune diseases
EP0292257A3 (en) Peptides having anf activity
AU585167B2 (en) Novel substrate peptides
RU94036002A (ru) Ингибитор протеазы, днк, вектор, клетка, способ получения ингибитора, фармацевтическая композиция

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401